Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 5
2003 2
2005 2
2007 2
2008 2
2009 9
2010 6
2011 5
2012 7
2013 11
2014 16
2015 15
2016 26
2017 19
2018 18
2019 19
2020 18
2021 14
2022 4
2023 7
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

185 results

Results by year

Filters applied: . Clear all
Page 1
Antibody-drug conjugates come of age in oncology.
Dumontet C, Reichert JM, Senter PD, Lambert JM, Beck A. Dumontet C, et al. Among authors: beck a. Nat Rev Drug Discov. 2023 Aug;22(8):641-661. doi: 10.1038/s41573-023-00709-2. Epub 2023 Jun 12. Nat Rev Drug Discov. 2023. PMID: 37308581 Review.
Antibody-Drug Conjugates: The Last Decade.
Joubert N, Beck A, Dumontet C, Denevault-Sabourin C. Joubert N, et al. Among authors: beck a. Pharmaceuticals (Basel). 2020 Sep 14;13(9):245. doi: 10.3390/ph13090245. Pharmaceuticals (Basel). 2020. PMID: 32937862 Free PMC article. Review.
Therapeutic Fc-fusion proteins: Current analytical strategies.
Duivelshof BL, Murisier A, Camperi J, Fekete S, Beck A, Guillarme D, D'Atri V. Duivelshof BL, et al. Among authors: beck a. J Sep Sci. 2021 Jan;44(1):35-62. doi: 10.1002/jssc.202000765. Epub 2020 Sep 29. J Sep Sci. 2021. PMID: 32914936 Review.
Structure, heterogeneity and developability assessment of therapeutic antibodies.
Xu Y, Wang D, Mason B, Rossomando T, Li N, Liu D, Cheung JK, Xu W, Raghava S, Katiyar A, Nowak C, Xiang T, Dong DD, Sun J, Beck A, Liu H. Xu Y, et al. Among authors: beck a. MAbs. 2019 Feb/Mar;11(2):239-264. doi: 10.1080/19420862.2018.1553476. Epub 2018 Dec 17. MAbs. 2019. PMID: 30543482 Free PMC article. Review.
[Immunotoxins and immunocytokines].
Contet A, Caussanel V, Beck A, Lowe P. Contet A, et al. Among authors: beck a. Med Sci (Paris). 2019 Dec;35(12):1054-1061. doi: 10.1051/medsci/2019205. Epub 2020 Jan 6. Med Sci (Paris). 2019. PMID: 31903917 Free article. Review. French.
Why is there no biosimilar of Erbitux®?
Douez E, D'Atri V, Guillarme D, Antier D, Guerriaud M, Beck A, Watier H, Foucault-Fruchard L. Douez E, et al. Among authors: beck a. J Pharm Biomed Anal. 2023 Sep 20;234:115544. doi: 10.1016/j.jpba.2023.115544. Epub 2023 Jun 22. J Pharm Biomed Anal. 2023. PMID: 37418870 Free article. Review.
The amazing, multipurpose antibody.
Beck A, Reichert JM. Beck A, et al. MAbs. 2011 May-Jun;3(3):221-2. doi: 10.4161/mabs.3.3.15625. Epub 2011 May 1. MAbs. 2011. PMID: 21487245 Free PMC article. No abstract available.
10th antibody industrial symposium: new developments in antibody and adoptive cell therapies.
Antunes A, Alvarez-Vallina L, Bertoglio F, Bouquin N, Cornen S, Duffieux F, Ferré P, Gillet R, Jorgensen C, Leick MB, Maillère B, Negre H, Pelegrin M, Poirier N, Reusch D, Robert B, Serre G, Vicari A, Villalba M, Volpers C, Vuddamalay G, Watier H, Wurch T, Zabeau L, Zielonka S, Zhang B, Beck A, Martineau P. Antunes A, et al. Among authors: beck a. MAbs. 2023 Jan-Dec;15(1):2211692. doi: 10.1080/19420862.2023.2211692. MAbs. 2023. PMID: 37184206 Free PMC article.
185 results